home / stock / leas / leas quote
Last: | $0.0002 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0002 |
Close: | $0.0002 |
High: | $0.0002 |
Low: | $0.0002 |
Volume: | 200,000 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0002 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 200,000 | 04-26-2024 |
$0.0002 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 1,000 | 04-25-2024 |
$0.0001 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 500,501 | 04-24-2024 |
$0.0027 | $0.003 | $0.0027 | $0.003 | $0.0025 | 681,510 | 04-19-2024 |
$0.0027 | $0.0056 | $0.0027 | $0.0056 | $0.0027 | 14,712,109 | 04-18-2024 |
$0.0055 | $0.0065 | $0.0055 | $0.0065 | $0.00325 | 16,848,081 | 04-17-2024 |
$0.00626 | $0.0073 | $0.00626 | $0.008 | $0.006 | 1,559,042 | 04-16-2024 |
$0.0071 | $0.0067 | $0.0071 | $0.008 | $0.0052 | 6,110,889 | 04-15-2024 |
$0.0079 | $0.0065 | $0.0079 | $0.0085 | $0.0063 | 7,739,912 | 04-12-2024 |
$0.007 | $0.0075 | $0.007 | $0.0098 | $0.00664 | 5,265,455 | 04-11-2024 |
$0.007 | $0.006 | $0.007 | $0.008 | $0.0051 | 3,916,709 | 04-10-2024 |
$0.0066 | $0.0062 | $0.0066 | $0.0066 | $0.0059 | 1,283,582 | 04-09-2024 |
$0.006 | $0.0069 | $0.006 | $0.0069 | $0.0054 | 1,695,690 | 04-08-2024 |
$0.00541 | $0.0062 | $0.00541 | $0.0062 | $0.005 | 1,701,066 | 04-05-2024 |
$0.0062 | $0.0063 | $0.0062 | $0.0065 | $0.0055 | 1,004,008 | 04-04-2024 |
$0.00634 | $0.0063 | $0.00634 | $0.0069 | $0.005 | 3,342,725 | 04-03-2024 |
$0.00595 | $0.006 | $0.00595 | $0.0063 | $0.005 | 1,214,730 | 04-02-2024 |
$0.0059 | $0.0054 | $0.0059 | $0.007 | $0.0038 | 7,431,017 | 04-01-2024 |
$0.007 | $0.0072 | $0.007 | $0.0075 | $0.0041 | 7,245,392 | 03-29-2024 |
$0.007 | $0.0072 | $0.007 | $0.0075 | $0.0041 | 7,245,392 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Strategic Asset Leasing Inc. Company Name:
LEAS Stock Symbol:
OTCMKTS Market:
ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement PR Newswire ANEW MEDICAL is developing a platform and commercializing novel gene therapies to alleviate and/or reverse the progression of neurodegenerative...
Gene therapy candidate for amyotrophic lateral sclerosis (ALS) demonstrates bioactivities in a murine model of the disease PR Newswire NEW YORK , March 13, 2023 /PRNewswire/ -- ANEW MEDICAL, INC . ("ANEW'' or the "Company"), a medical product development comp...
ANEW MEDICAL Receives Notification of Issuance of Alzheimer's Gene Therapy Patent and Claims by the European Patent Organization (EPO) PR Newswire NEW YORK , Dec. 26, 2022 /PRNewswire/ -- ANEW MEDICAL, INC., a technology and medical product holding company (OTC: ...